Dexcom (DXCM) Non-cash Items (2011 - 2012)

Dexcom (DXCM) reported Non-cash Items of $45.5 million for Q4 2012, up 598.6% year-over-year from $6.5 million in Q1 2012, and up 598.6% quarter-over-quarter from $6.5 million in Q4 2011.

Dexcom (DXCM) Non-cash Items (2011 - 2012) Analysis & Trends

Dexcom (DXCM) has 2 years of Non-cash Items data on file, last reported at $45.5 million in Q4 2012.

  • Non-cash Items for Q4 2012 came in at $45.5 million, up 598.6% year-over-year; the trailing twelve-month figure through Dec 2012 was $45.5 million (up 598.6% YoY), and the FY2012 annual result was $45.5 million, up 598.6% from the prior year.
  • Non-cash Items grew to $45.5 million in Q4 2012 per DXCM's latest filing, from $6.5 million in the prior quarter.
  • Over five years, Non-cash Items peaked at $45.5 million in Q4 2012 and troughed at $6.5 million in Q4 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Zimmer Biomet Holdings 17.18 Bn 16.77 Bn 1.51 Bn

Historic Data

Download Data
DateValue
Dec 31, 2012 45.50 Mn
Dec 31, 2012 45.50 Mn
Dec 31, 2011 6.51 Mn
Dec 31, 2011 6.51 Mn